• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Medical comorbidities associated with poor semen quality

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
December 14, 2014
in Chronic Disease, Obstetrics
Reading Time: 3 mins read
Medical comorbidities associated with poor semen quality
Share on FacebookShare on TwitterShare on LinkedIn

1. The severity of medical comorbidities was inversely associated with semen quality.

2. Hypertension, peripheral vascular and cerebrovascular disease, and nonischemic heart disease were associated with higher rates of semen abnormalities.

Evidence Rating Level: 3 (Average)  

Study Rundown: Infertility, defined as the inability to become pregnant after one year of regular unprotected intercourse or after 6 months of regular unprotected intercourse after the age of age 35, affects roughly 15 percent of couples in the United States trying to conceive each year. As couples wait until older ages to have children, these numbers are likely to increase. Many think of infertility as associated solely with women, but in a 2002 CDC study, 7.5 percent of all sexually experienced men under 45 reported having seen a fertility doctor. In this study, researchers aimed to identify an association between semen quality and current health status in a cohort of men presenting for infertility workup.

Men with higher comorbidity scores at the time of infertility evaluation were more likely to have abnormal semen parameters, including lower semen volume, concentration, motility, total sperm count and morphology scores. Specifically, men with hypertension, peripheral vascular and cerebrovascular disease, and nonischemic heart disease had higher rates of semen abnormalities. While prior studies have found a link between individual diseases such as metabolic syndrome and male infertility, this is the first study to look at comprehensive health and semen quality. Limitations included the study population, which was composed solely of men who presented for infertility evaluation at a specialized medical center and likely do not reflect the general population. Additionally, researchers did not account for a number of potential confounders, including treatment regimen and lifestyle factors. Prospective studies including a non-fertile control group are needed to further explore these findings.

Click to read the study in Fertility and Sterility

RELATED REPORTS

Letrozole (Femara) improves sperm concentration in men with spermatogenic failure

Use of antioxidants does not improve fertility in men trying to conceive

Relevant Reading: Semen quality, infertility and mortality in the USA

In-Depth [cross-sectional study]: Researchers collected semen data from 9387 men evaluated for infertility from 1994-2011 at a high volume fertility clinic. The cohort was stratified based on the Charlson comorbidity index, a measurement that assesses the severity of comorbid medical conditions by predicting a patient’s 10-year mortality, and relationship with semen quality was assessed.

A higher Charlson comorbidity index was associated with lower semen volume, concentration, motility, total sperm count and morphology scores (p-trend<0.01 for all parameters except morphology, where p-trend=0.04). When diseases (excluding cancers) were stratified by organ system, endocrine (p=0.02), genitourinary (p<0.01) and skin diseases (p=0.01) were associated with abnormal semen parameters. Within circulatory system diseases, hypertension (p=0.02), peripheral vascular and cerebrovascular disease (p=0.05), and nonischemic heart disease (p=0.04) were associated with semen abnormalities.

More from this author: Contained morcellation for benign gynecologic surgeries feasible, minimize surgical risk, Oocyte vitrification not associated with adverse obstetric or perinatal outcomes, IUD contraception equally safe in teenagers as in older women, No-cost contraception reduces unintended pregnancy rates, Tampon DNA sensitive test for high grade ovarian cancer

Image: CC ScienceGenetics WikimediaCommons

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Male Infertilityreproductive endocrinology
Previous Post

Colonic byproduct may decrease long-term weight gain

Next Post

Preeclampsia linked to autism and developmental delay

RelatedReports

Challenges and feasibility of fertility preservation in feminizing transgender youth
Chronic Disease

Letrozole (Femara) improves sperm concentration in men with spermatogenic failure

July 13, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Urology

Use of antioxidants does not improve fertility in men trying to conceive

January 13, 2026
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Bariatric surgery may improve rates for spontaneous ovulation in patients with polycystic ovarian syndrome and obesity

June 12, 2024
Severe endometriosis associated with poor IVF outcomes
Chronic Disease

Intracytoplasmic sperm injection offers no benefit over in-vitro fertilization for non-severe male factor infertility

April 12, 2024
Next Post
Preeclampsia linked to autism and developmental delay

Preeclampsia linked to autism and developmental delay

Anaerobic antibiotics may decrease mortality in infants with necrotizing enterocolitis

Anaerobic antibiotics may decrease mortality in infants with necrotizing enterocolitis

Study evaluates family-initiated medication dialogues on rounds

Study evaluates family-initiated medication dialogues on rounds

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome
  • Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Limited-time Deep research trial
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.